share_log

Investing in MetLife (NYSE:MET) Five Years Ago Would Have Delivered You a 82% Gain

Investing in MetLife (NYSE:MET) Five Years Ago Would Have Delivered You a 82% Gain

五年前投資大都會人壽(紐約證券交易所代碼:MET)將爲您帶來82%的收益
Simply Wall St ·  05/14 18:56

The main point of investing for the long term is to make money. But more than that, you probably want to see it rise more than the market average. Unfortunately for shareholders, while the MetLife, Inc. (NYSE:MET) share price is up 52% in the last five years, that's less than the market return. Some buyers are laughing, though, with an increase of 43% in the last year.

長期投資的要點是賺錢。但不僅如此,你可能希望看到它的漲幅超過市場平均水平。對於股東來說,不幸的是,儘管大都會人壽公司(紐約證券交易所代碼:MET)的股價在過去五年中上漲了52%,但仍低於市場回報率。但是,一些買家笑了,去年增長了43%。

So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.

因此,讓我們評估過去5年的基本面,看看它們是否與股東回報步調一致。

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

引用巴菲特的話說:“船隻將在世界各地航行,但Flat Earth Society將蓬勃發展。市場上的價格和價值之間將繼續存在巨大差異...”考慮市場對公司的看法發生了怎樣的變化的一種不完美但簡單的方法是將每股收益(EPS)的變化與股價走勢進行比較。

MetLife's earnings per share are down 10.0% per year, despite strong share price performance over five years.

儘管五年來股價表現強勁,但大都會人壽的每股收益每年下降10.0%。

Essentially, it doesn't seem likely that investors are focused on EPS. Because earnings per share don't seem to match up with the share price, we'll take a look at other metrics instead.

從本質上講,投資者似乎不太可能將注意力集中在每股收益上。由於每股收益似乎與股價不符,因此我們將改用其他指標。

It is not great to see that revenue has dropped by 0.1% per year over five years. It certainly surprises us that the share price is up, but perhaps a closer examination of the data will yield answers.

看到收入在五年內每年下降0.1%,這並不令人滿意。股價上漲無疑使我們感到驚訝,但也許仔細研究數據會得出答案。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下圖中看到收入和收入隨時間推移而發生的變化(點擊圖表查看確切值)。

earnings-and-revenue-growth
NYSE:MET Earnings and Revenue Growth May 14th 2024
紐約證券交易所:大都會收益和收入增長 2024 年 5 月 14 日

MetLife is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. You can see what analysts are predicting for MetLife in this interactive graph of future profit estimates.

大都會人壽爲投資者所熟知,許多聰明的分析師都試圖預測未來的利潤水平。您可以在這張未來利潤估計的交互式圖表中看到分析師對大都會人壽的預測。

What About Dividends?

分紅呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for MetLife the TSR over the last 5 years was 82%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence!

除了衡量股價回報率外,投資者還應考慮股東總回報率(TSR)。股東總回報率是一種回報計算方法,它考慮了現金分紅的價值(假設收到的任何股息都經過再投資)以及任何貼現資本籌集和分拆的計算價值。可以說,股東總回報率更全面地描述了股票產生的回報。我們注意到,大都會人壽在過去5年的股東總回報率爲82%,好於上述股價回報率。而且,猜測股息支付在很大程度上解釋了這種分歧是沒有好處的!

A Different Perspective

不同的視角

It's nice to see that MetLife shareholders have received a total shareholder return of 48% over the last year. That's including the dividend. That's better than the annualised return of 13% over half a decade, implying that the company is doing better recently. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. It's always interesting to track share price performance over the longer term. But to understand MetLife better, we need to consider many other factors. Even so, be aware that MetLife is showing 3 warning signs in our investment analysis , you should know about...

很高興看到大都會人壽股東在過去一年中獲得了48%的股東總回報率。這包括股息。這比五年來13%的年化回報率要好,這意味着該公司最近的表現更好。持樂觀態度的人可能會將最近股東總回報率的改善視爲業務本身隨着時間的推移而變得更好。長期跟蹤股價表現總是很有意思的。但是,爲了更好地了解大都會人壽,我們需要考慮許多其他因素。即便如此,請注意,大都會人壽在我們的投資分析中顯示出3個警告信號,您應該知道...

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果你想看看另一家公司——一家財務狀況可能優異的公司——那麼千萬不要錯過這份已經證明自己可以增加收益的公司的免費名單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論